Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,254 | -5,832 | -2,737 | -12,245 | -9,137 |
| Depreciation Amortization | 21 | 14 | 7 | 27 | 21 |
| Accounts payable and accrued liabilities | -178 | -574 | -270 | 845 | 456 |
| Other Working Capital | -699 | -1,635 | -1,315 | 752 | 1,456 |
| Other Operating Activity | 1,162 | 1,296 | 451 | 3,381 | 2,188 |
| Operating Cash Flow | $-8,948 | $-6,732 | $-3,864 | $-7,239 | $-5,016 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -350 | -350 | N/A | -525 | -135 |
| Investing Cash Flow | $-350 | $-350 | $N/A | $-525 | $-135 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,469 | 10,469 |
| Debt Repayment | N/A | N/A | N/A | -114 | -10 |
| Common Stock Issued | 14,250 | 14,250 | 14,250 | 0 | 0 |
| Other Financing Activity | 0 | 0 | 0 | -997 | -998 |
| Financing Cash Flow | $14,250 | $14,250 | $14,250 | $9,358 | $9,462 |
| Beginning Cash Position | 5,934 | 5,934 | 5,934 | 4,340 | 4,340 |
| End Cash Position | 10,886 | 13,102 | 16,320 | 5,934 | 8,651 |
| Net Cash Flow | $4,953 | $7,169 | $10,387 | $1,594 | $4,311 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,948 | -6,732 | -3,864 | -7,239 | -5,016 |
| Capital Expenditure | -350 | -350 | N/A | -525 | -135 |
| Free Cash Flow | -9,298 | -7,082 | -3,864 | -7,764 | -5,151 |